Keri Feldman

480 total citations
10 papers, 333 citations indexed

About

Keri Feldman is a scholar working on Neurology, Molecular Biology and Epidemiology. According to data from OpenAlex, Keri Feldman has authored 10 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 3 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Keri Feldman's work include Traumatic Brain Injury and Neurovascular Disturbances (7 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers) and Sepsis Diagnosis and Treatment (2 papers). Keri Feldman is often cited by papers focused on Traumatic Brain Injury and Neurovascular Disturbances (7 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers) and Sepsis Diagnosis and Treatment (2 papers). Keri Feldman collaborates with scholars based in United States and Antigua and Barbuda. Keri Feldman's co-authors include Patrick M. Kochanek, Robert S. B. Clark, P. David Adelson, Hülya Bayır, Michael J. Bell, Stephen R. Wisniewski, Rajesh K. Aneja, Sandra D. W. Buttram, Edwin K. Jackson and Rachel P. Berger and has published in prestigious journals such as Critical Care Medicine, Journal of Neurotrauma and Pediatric Critical Care Medicine.

In The Last Decade

Keri Feldman

10 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keri Feldman United States 7 189 135 76 72 67 10 333
Margaret A. Satchell United States 5 236 1.2× 143 1.1× 135 1.8× 90 1.3× 16 0.2× 8 374
Jessica S. Wallisch United States 8 206 1.1× 178 1.3× 82 1.1× 83 1.2× 29 0.4× 19 352
Mark W. Uhl United States 5 249 1.3× 154 1.1× 87 1.1× 48 0.7× 75 1.1× 7 337
Ding-Bo Yang China 12 228 1.2× 124 0.9× 115 1.5× 23 0.3× 34 0.5× 23 350
Ribal Darwish United States 9 166 0.9× 146 1.1× 73 1.0× 28 0.4× 33 0.5× 17 344
Georgia F. Symons Australia 9 167 0.9× 149 1.1× 167 2.2× 56 0.8× 44 0.7× 16 351
Florian Schlenk Germany 8 362 1.9× 50 0.4× 67 0.9× 18 0.3× 70 1.0× 8 472
Benjamin E. Zusman United States 11 230 1.2× 121 0.9× 97 1.3× 94 1.3× 20 0.3× 27 367
Daniela F. Requena United States 10 88 0.5× 148 1.1× 62 0.8× 19 0.3× 26 0.4× 15 334
Paul Muizelaar United States 6 348 1.8× 142 1.1× 165 2.2× 125 1.7× 12 0.2× 11 485

Countries citing papers authored by Keri Feldman

Since Specialization
Citations

This map shows the geographic impact of Keri Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keri Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keri Feldman more than expected).

Fields of papers citing papers by Keri Feldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keri Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keri Feldman. The network helps show where Keri Feldman may publish in the future.

Co-authorship network of co-authors of Keri Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of Keri Feldman. A scholar is included among the top collaborators of Keri Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keri Feldman. Keri Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Beers, Sue R., Amy J. Houtrow, Craig M. Smith, et al.. (2017). 818: SERUM BIOMARKER RELATIONSHIPS WITH FUNCTIONAL IMPAIRMENT FOLLOWING ACUTE PEDIATRIC BRAIN INJURY. Critical Care Medicine. 46(1). 393–393. 2 indexed citations
3.
Jackson, Travis C., C. Edward Dixon, Robert S. B. Clark, et al.. (2016). Polynitroxylated Pegylated Hemoglobin—A Novel, Small Volume Therapeutic for Traumatic Brain Injury Resuscitation: Comparison to Whole Blood and Dose Response Evaluation. Journal of Neurotrauma. 34(7). 1337–1350. 12 indexed citations
4.
Newell, Elizabeth A., David Shellington, Dennis Simon, et al.. (2015). Cerebrospinal Fluid Markers of Macrophage and Lymphocyte Activation After Traumatic Brain Injury in Children. Pediatric Critical Care Medicine. 16(6). 549–557. 37 indexed citations
5.
Au, Alicia K., Rajesh K. Aneja, Michael J. Bell, et al.. (2012). Cerebrospinal Fluid Levels of High-Mobility Group Box 1 and Cytochrome C Predict Outcome after Pediatric Traumatic Brain Injury. Journal of Neurotrauma. 29(11). 2013–2021. 88 indexed citations
6.
Empey, Philip E., Samuel M. Poloyac, Stephen R. Wisniewski, et al.. (2010). Endothelin-1 Is Increased in Cerebrospinal Fluid and Associated with Unfavorable Outcomes in Children after Severe Traumatic Brain Injury. Journal of Neurotrauma. 27(10). 1819–1825. 45 indexed citations
7.
Blasiole, Brian, Vincent A. Vagni, Keri Feldman, et al.. (2010). Resuscitation of Experimental Traumatic Brain Injury and Hemorrhagic Shock in Mice: Acute Effects of Polynitroxylated Pegylated Hemoglobin and 100% Oxygen. 1 indexed citations
8.
Buttram, Sandra D. W., Stephen R. Wisniewski, Edwin K. Jackson, et al.. (2007). Multiplex Assessment of Cytokine and Chemokine Levels in Cerebrospinal Fluid following Severe Pediatric Traumatic Brain Injury: Effects of Moderate Hypothermia. Journal of Neurotrauma. 24(11). 1707–1718. 115 indexed citations
9.
Lai, Yi‐Chen, Keri Feldman, & Robert S. B. Clark. (2005). Enzyme-linked immunosorbent assays (ELISAs). Critical Care Medicine. 33(Suppl). S433–S434. 13 indexed citations
10.
Bayır, Hülya, Robert S. B. Clark, Valerian E. Kagan, et al.. (2005). MECHANISMS OF TYROSINE NITRATION OF MNSOD AFTER TRAUMATIC BRAIN INJURY.. Critical Care Medicine. 33. A16–A16. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret A. Satchell Breakdown of academic impact, for papers by Jessica S. Wallisch Breakdown of academic impact, for papers by Mark W. Uhl Breakdown of academic impact, for papers by Ding-Bo Yang Breakdown of academic impact, for papers by Ribal Darwish Breakdown of academic impact, for papers by Georgia F. Symons Breakdown of academic impact, for papers by Florian Schlenk Breakdown of academic impact, for papers by Benjamin E. Zusman Breakdown of academic impact, for papers by Daniela F. Requena Breakdown of academic impact, for papers by Paul Muizelaar
Rankless by CCL
2026